Expression of concern
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Paper Information
Record ID:
35124
Author(s):
Journal:
Publication Date:
December 01, 2012
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Medicine 1, Agaplesion Markus Hospital, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany
- Division of Gastroenterology, Department of Medicine, MtSinai Hospital and University Health Network
- University of Toronto, 600 University Avenue, Toronto, ON, Canada
- M5G 1X5 and University of Leuven, Belgium
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1561)
1561
Total Citations239
Post-Retraction(15.3%)
1316
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
9
Within 30 days
111
Within 1 year
61
After 2+ years
1218
Days since retraction (latest)
An experimental and computational analysis on 2,6-diamine-7H-purine ligand with spectroscopic, AIM, NLO and biological activity
Kamalanathan Guna, P. Sakthivel, I. Ragavan et al. (6 authors)
Optics & Laser Technology
Published: Jul 2023
4 citations
4 citations
552 days after retraction
Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Eun Mi Song, Soo‐Young Na, Sung Noh Hong et al. (6 authors)
Intestinal Research
Open Access
Published: Jul 2023
11 citations
11 citations
550 days after retraction
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies
Louis Calméjane, David Laharie, Julien Kirchgesner et al. (4 authors)
United European Gastroenterology Journal
Open Access
Published: Jul 2023
33 citations
33 citations
542 days after retraction
A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses
Shaocong Mo, Bryan Jin, Yujen Tseng et al. (14 authors)
Journal of Translational Medicine
Open Access
Published: Jul 2023
6 citations
6 citations
535 days after retraction
Deep learning model for distinguishing Mayo endoscopic subscore 0 and 1 in patients with ulcerative colitis
Ji Eun Kim, Yoon Ho Choi, Yeong Chan Lee et al. (11 authors)
Scientific Reports
Open Access
Published: Jul 2023
8 citations
8 citations
535 days after retraction
Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis
Bruce E. Sands, Stefan Schreiber, Irina Blumenstein et al. (6 authors)
Journal of Crohn s and Colitis
Open Access
Published: Jul 2023
31 citations
31 citations
534 days after retraction
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Jul 2023
27 citations
27 citations
525 days after retraction
Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin et al. (10 authors)
Nature Reviews Rheumatology
Published: Jun 2023
25 citations
25 citations
521 days after retraction
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease
Daniela Amidžić Klarić, Jelena Kovačić, Mario-Livio Jeličić et al. (9 authors)
Pharmaceuticals
Open Access
Published: Jun 2023
1 citation
1 citation
510 days after retraction
The Potential of Natural Oils to Improve Inflammatory Bowel Disease
Yaxi Zhou, Diandian Wang, Hao Duan et al. (6 authors)
Nutrients
Open Access
Published: Jun 2023
7 citations
7 citations
493 days after retraction
Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis
Shreyak Sharma, Darrick K. Li, Louis J. Levine et al. (8 authors)
Crohn s & Colitis 360
Open Access
Published: May 2023
2 citations
2 citations
492 days after retraction
Comparing Patient Reported Outcomes among Anti-TNF Experienced Patients with Ulcerative Colitis Initiating Vedolizumab versus Tofacitinib
Michael D. Kappelman, Millie D. Long, Xian Zhang et al. (16 authors)
Crohn s & Colitis 360
Open Access
Published: May 2023
1 citation
1 citation
490 days after retraction
Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
Thaís Gagno Grillo, Caroline Ferreira da Silva Mazeto Pupo Silveira, Ana Elisa Valencise Quaglio et al. (7 authors)
World Journal of Cardiology
Open Access
Published: May 2023
7 citations
7 citations
479 days after retraction
Genetic and dietary modulators of the inflammatory response in the gastrointestinal tract of the BXD mouse genetic reference population
Xiaoxu Li, Jean‐David Morel, Giorgia Benegiamo et al. (12 authors)
eLife
Open Access
Published: May 2023
4 citations
4 citations
478 days after retraction
Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
Fenna M. Jansen, Lisa Smits, Pepijn W. A. Thomas et al. (8 authors)
Digestive Diseases and Sciences
Open Access
Published: May 2023
1 citation
1 citation
463 days after retraction
Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis
Xue Lyu, Zhe Zhang, Xia Liu et al. (6 authors)
Journal of Inflammation Research
Open Access
Published: May 2023
3 citations
3 citations
462 days after retraction
Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them
Maro Kyriacou, Shellie Radford, Gordon W. Moran
BMJ Open Gastroenterology
Open Access
Published: May 2023
2 citations
2 citations
462 days after retraction
Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn’s Disease Initiating Vedolizumab Versus Ustekinumab
Michael D. Kappelman, James D. Lewis, X. Zhang et al. (14 authors)
Digestive Diseases and Sciences
Published: Apr 2023
1 citation
1 citation
459 days after retraction
Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics
Weitao Hu, Taiyong Fang, Mingxuan Zhou et al. (4 authors)
Scientific Reports
Open Access
Published: Apr 2023
6 citations
6 citations
444 days after retraction
Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease
Jeff Y. Yang, Jennifer L. Lund, Michele Jönsson Funk et al. (6 authors)
The American Journal of Gastroenterology
Published: Apr 2023
8 citations
8 citations
444 days after retraction
Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future
E C S D Oliveira, Ana Elisa Valencise Quaglio, Daniéla Oliveira Magro et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2023
30 citations
30 citations
444 days after retraction
CRAB score for prediction of colectomy within 2 years following admission for acute severe ulcerative colitis
Krishnadas Devadas, Suprabhat Giri, Jijo Varghese et al. (4 authors)
Saudi Journal of Gastroenterology
Open Access
Published: Apr 2023
1 citation
1 citation
438 days after retraction
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial
Geert D’Haens, Walter Reinisch, Stefan Schreiber et al. (9 authors)
Clinical Drug Investigation
Open Access
Published: Apr 2023
18 citations
18 citations
432 days after retraction
Identification of Critical Modules and Biomarkers of Ulcerative Colitis by Using WGCNA
Yifan Yuan, Na Li, Mingyue Fu et al. (4 authors)
Journal of Inflammation Research
Open Access
Published: Apr 2023
12 citations
12 citations
432 days after retraction
Structural, spectroscopic, electronic, Hirshfeld, QTAIM and biological predications of a hybrid 2,6-dichloropurine compound: A detailed density functional theoretical study
Kamalanathan Guna, P. Sakthivel, Joseph Iruthayaraj Ragavan et al. (6 authors)
Journal of the Indian Chemical Society
Published: Mar 2023
3 citations
3 citations
430 days after retraction
Probiotics in Irritable Bowel Syndrome: A Review Article
Shatakshi Sharma, Sunil Kumar, Sheeral Sajjad et al. (4 authors)
Cureus
Open Access
Published: Mar 2023
8 citations
8 citations
423 days after retraction
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks et al. (5 authors)
Frontiers in Microbiology
Open Access
Published: Feb 2023
15 citations
15 citations
395 days after retraction
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone
Tamás Resál, Katalin Mangó, P Bacsúr et al. (15 authors)
Expert Opinion on Drug Safety
Published: Feb 2023
2 citations
2 citations
394 days after retraction
Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cells
Hengyi Yu, Dongyan Li, Dong Xiang et al. (7 authors)
Heliyon
Open Access
Published: Feb 2023
5 citations
5 citations
394 days after retraction
Vitamin D3 alleviates inflammation in ulcerative colitis by activating the VDR-NLRP6 signaling pathway
Hongliang Gao, He Zhou, Zhiqiang Zhang et al. (6 authors)
Frontiers in Immunology
Open Access
Published: Feb 2023
14 citations
14 citations
380 days after retraction
Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy
Florian Poullenot, David Laharie
Cancers
Open Access
Published: Feb 2023
7 citations
7 citations
380 days after retraction
iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
Ferdinando D’Amico, Fernando Magro, Bénédicte Caron et al. (13 authors)
Journal of Clinical Medicine
Open Access
Published: Feb 2023
5 citations
5 citations
373 days after retraction
Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis
Harpreet Singh, Liam Wilson, T. Tencer et al. (4 authors)
ClinicoEconomics and Outcomes Research
Open Access
Published: Feb 2023
8 citations
8 citations
373 days after retraction
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff, Palle Bager, Johanna C. Escher et al. (16 authors)
Clinical Nutrition
Open Access
Published: Jan 2023
208 citations
208 citations
354 days after retraction
Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing
Noriyuki Kurimoto, Yu Nishida, Shuhei Hosomi et al. (15 authors)
PLoS ONE
Open Access
Published: Jan 2023
9 citations
9 citations
353 days after retraction
Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine
Pratul Karki, Ariya Kunwar, Nitish Sharma et al. (4 authors)
Cureus
Open Access
Published: Jan 2023
2 citations
2 citations
352 days after retraction
Clinical Diagnosis and Phar-maceutical Management of Inflammatory Bowel Disease
Amosy E. M’Koma
Medical Research Archives
Open Access
Published: Jan 2023
11 citations
11 citations
342 days after retraction
Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study
Maciej Jesionowski, Grażyna Rydzewska, Silvio Danese et al. (4 authors)
Gastroenterology Review
Open Access
Published: Jan 2023
342 days after retraction
RISK FACTORS FOR EARLY POSTOPERATIVE COMPLICATIONS IN ACUTE COLITIS IN THE ERA OF BIOLOGIC THERAPY
Lucas Faraco Sobrado, Fernando Noboru Cabral Mori, Carolina Bortolozzo Graciolli Facanali et al. (6 authors)
ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Open Access
Published: Jan 2023
3 citations
3 citations
342 days after retraction
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice
Marta Calvo, Yago González Lama, Belén Ruíz‐Antorán et al. (13 authors)
Crohn s & Colitis 360
Open Access
Published: Jan 2023
1 citation
1 citation
342 days after retraction
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines
R. Looser
Annals of Gastroenterology
Open Access
Published: Jan 2023
1 citation
1 citation
342 days after retraction
Protective effect of Melissa officinalis against acetic acid induced ulcerative colitis in rat models: an experimental study
Reza Shahriarirad
Annals of Gastroenterology
Open Access
Published: Jan 2023
342 days after retraction
Can we change the natural course of inflammatory bowel disease?
Catherine Le Berre, Silvio Danese, Laurent Peyrin‐Biroulet
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2023
22 citations
22 citations
342 days after retraction
Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
Kazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima et al. (19 authors)
Inflammatory Intestinal Diseases
Open Access
Published: Jan 2023
342 days after retraction
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
Piotr Eder, Michał Łodyga, Magdalena Gawron-Kiszka et al. (14 authors)
Gastroenterology Review
Open Access
Published: Jan 2023
32 citations
32 citations
342 days after retraction
Exposure to Anti-TNF Medications Does Not Increase the Risk of Cardiac Arrhythmia in Inflammatory Bowel Disease: A Population-Based Cohort Study
Lone Larsen, K. D. Olsen, Heidi S. Christensen et al. (5 authors)
Gastro Hep Advances
Open Access
Published: Jan 2023
2 citations
2 citations
342 days after retraction
Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar
Rosanne W. Meijboom, Helga Gardarsdóttir, Matthijs L. Becker et al. (7 authors)
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2023
1 citation
1 citation
342 days after retraction
Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
Geert D’Haens, Ekaterina Safroneeva, Helen C. Thorne et al. (4 authors)
Inflammatory Intestinal Diseases
Open Access
Published: Jan 2023
2 citations
2 citations
342 days after retraction
Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis
Taku Kobayashi, Eri Udagawa, Lisa Hirose et al. (4 authors)
Intestinal Research
Open Access
Published: Dec 2022
3 citations
3 citations
324 days after retraction
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
Xiaoyan Lu, James Jarrett, Susannah Sadler et al. (6 authors)
International Journal of Clinical Pharmacy
Open Access
Published: Dec 2022
10 citations
10 citations
319 days after retraction
Quick Stats
Total Citations:
1561
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025